Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Healthtronics
>
Now what?!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4956729"]What does this mean for the future?</p><p><br /></p><p>1/9/2014 8:15 AM ET</p><p>Endo Health Solutions (ENDP: Quote) has agreed to divest its HealthTronics business to Altaris Capital Partners, LLC for an upfront cash payment of $85 million, subject to cash and other working capital adjustments. Further, Endo would receive rights to additional cash payments of up to $45 million based on the future operating performance of HealthTronics for up to $130 million.</p><p><br /></p><p>Earlier, the company divested two operating units of HealthTronics, its image guided radiation therapy or IGRT and its anatomical pathology laboratory businesses, for around $25 million.</p><p><br /></p><p>Today's transaction and the prior announced sale of HealthTronics' anatomical pathology business and IGRT business completes Endo's full divestiture of all HealthTronics businesses. The transaction may close in the first quarter of 2014, including the expiration or termination of any applicable waiting periods under applicable competition laws.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4956729"]What does this mean for the future? 1/9/2014 8:15 AM ET Endo Health Solutions (ENDP: Quote) has agreed to divest its HealthTronics business to Altaris Capital Partners, LLC for an upfront cash payment of $85 million, subject to cash and other working capital adjustments. Further, Endo would receive rights to additional cash payments of up to $45 million based on the future operating performance of HealthTronics for up to $130 million. Earlier, the company divested two operating units of HealthTronics, its image guided radiation therapy or IGRT and its anatomical pathology laboratory businesses, for around $25 million. Today's transaction and the prior announced sale of HealthTronics' anatomical pathology business and IGRT business completes Endo's full divestiture of all HealthTronics businesses. The transaction may close in the first quarter of 2014, including the expiration or termination of any applicable waiting periods under applicable competition laws.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Healthtronics
>
Now what?!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Medical Equipment/Device Sales
>
Healthtronics
>
Now what?!
>